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In Pakistan, more than 10 million people are living with hepatitis C virus (HCV) with high morbidity and 
mortality. The aims of the present study are to report HCV core gene sequences from Pakistani 
population and perform their sequence comparison/phylogenetic analysis. The core gene of HCV has 
been cloned from six different patients and sequences submitted at the National Center of Biotechnology 
Information (NCBI). Nucleotides and deduced amino acid sequence comparison of six isolates was 
performed with each other and with two HCV genotype 3a type examples reported from Japan. 
Phylogenetic tree of HCV core sequences was constructed using CLC software. Nucleotides sequence 
comparison showed that our sequences have 94 to 96% homology with NZL1 strain and 90 to 93% 
homology with HCV-K3A/650 strain. Deduced amino acid sequence comparison showed that our 
sequences have 92 to 98% homology with NZL1 strain and 88 to 94% homology with HCV-K3A/650 strain. 
Phylogenetic analysis suggests that our sequences are clustered with sequences reported from Japan. 
This is the first phylogenetic analysis of HCV core gene from Pakistani population. Our sequences and 
sequences from Japan are grouped into same cluster in the phylogenetic tree. Sequence comparison and 
phylogenetic analysis showed that our isolates have high homology with Japanese isolates. 
 





Hepatitis C virus (HCV) was discovered in 1989 as the 
major causative agent of non-A and non-B hepatitis (Rice, 
1996). It belongs to Flaviviridae family and is a plus 
stranded RNA virus (Choo et al., 1999). About 200 million 
people are infected with HCV worldwide, which covers 
about 3.3% of the world population (Waheed et al., 2009). 
Most patients with HCV persistent infection develop chronic 
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It was estimated by the World Health Organization in 
2004 that the annual deaths due to liver cancer caused 
by HCV and cirrhosis were 308,000 and 785,000, respec-
tively. HCV has six major genotypes and their distribution 
depends on the geographic area and transmission routes. 
In Pakistan, the major genotype of HCV is 3a (Waheed et 
al., 2009; Turhan et al., 2005). 
Pakistan is a developing country of 180 million people 
with low health and educational standards. Due to non 
implementation of international standards regarding blood 
transfusions, reuse of syringes and needles, poor steri-
lization practice by doctors, dentists and barbers, lack of 
awareness, the prevalence of HCV is increasing. HCV 
prevalence is 4.95% in general and 57% in IDU popu-
lation of Pakistan (Waheed et al., 2009). 
The genome of HCV comprises of a linear RNA mole-
cule of 9600 nucleotides, with single open reading frame 
encoding a polyprotein precursor of 3000 amino acids. 
The 5’ region of the viral RNA encodes for the structural 
proteins (C, E1 and E2), followed by the nonstructural 
proteins (NS2, NS3, NS4A, NS4B, NS5A and NS5B). 




Table 1. Demography of patients.  
  
Accession no. Sex Age Genotype ALT Viral Titer 
GQ180059 Male 24 years 3a 56 5.6 x 106 
GQ180060 Female 28 years 3a 16 5.6 x 105 
GQ180061 Male 40 years 3a 26 1.5 x 105 
GQ180062 Female 32 years 3a 68 6.5 x 107 
GQ180063 Female 42 years 3a 55 1.1 x 106 




Both host and viral proteases cleave the polyprotein 
into at least 10 different proteins (Major and Feinstone, 
1997; Santolini et al., 1994). The HCV core protein is highly 
basic, RNA-binding protein which is responsible for the 
formation of viral capsid (Yasui et al., 1998). Full length core 
sequence is required for the production of E2 
glycoprotein carrying N linked glycosylation (Zhu et al., 
2002). It contains 191 amino acids with three different 
domains: an N-terminal hydrophilic domain of 120 amino 
acids (domain D1), a C-terminal hydrophobic domain of 
about 50 amino acids (domain D2) and the last 20 amino 
acids (domain D3) (Santolini et al., 1994). D1 domain 
contains many positively charged amino acids and is 
involved in RNA binding and nuclear localization due to 
the presence of three predicted nuclear localization 
signals (NLS) (Chang et al., 1994). Domain D2 is 
responsible for core protein association with outer 
mitochondria membranes, endoplasmic reticulum (ER) 
membranes and lipid droplets (Schwer et al., 2004). 
Domain D3 serve as a signal peptide for the downstream 
envelope protein E1 (Santolini et al., 1994). Core protein 
also have role in apoptosis and malignant transformation 
of cells (Yan et al., 2008; Liu et al., 2002). In this study, 
we reported HCV core gene sequences from six different 
patients from Pakistani population. Their sequence 
analysis and phylogenetic studies were performed by 
comparing them with reported HCV core sequences, from 
different genotypes. HCV core gene was selected in this 
study because most genotype systems are from this 
region and it is quite easy to amplify this region. 
 
 
MATERIALS AND METHODS     
 
RNA extraction and polymerase chain reaction (PCR) 
 
Randomly selected HCV positive patients from the genotype 3a 
were included in this study; their demography is shown in Table 1. 
1300 ul of blood sample was taken in ethylenediaminetetraacetic 
acid (EDTA) vacutainer tubes and centrifuged at 12,000 g for 2 min 
to get the serum. Viral RNA extraction was done by using Qiagen 
RNA extraction kit according to the manufacturer protocols.  
Specific primers were designed by the sequence comparison of 
NZL1 strain and HCV-K3A/650 strain of genotype 3a. The sequences 
of primers were, 5’- CCCGAATTCGCCATGAGCACACTTCCTAA 
ACCTCAAG – 3’ (sense) and 5’–CCCGCGGCCGCTTAACTGGCT 
GCTGGATGAAT TAAGC–3' (antisense). These primers  amplified  a  
573  bp  core region from HCV positive samples. 
The RNA extracted was taken as template for the complementary 
DNA (cDNA) synthesis. The reaction mixture for reverse transcri-
ption had a total volume of 20 ul which contained 13 ul of RNA, 1 ul 
dNTPs (10 mM), 20 units of molony murine leukemia virus reverse 
transcriptase enzyme (Fermentas), 4 ul M.Mulv buffer and 1 ul spe-
cific antisense primer. Cycle conditions for cDNA were as follows: 
42°C for 55 min followed by 70°C for 10 min. 
The PCR reaction mixture contained 5 ul of cDNA as template, 1 
ul of each sense and antisense primer, 2 ul of dNTPs (2 mM), 2.5 ul 
of Dream Taq buffer, 13 ul of nuclease free water and 1.5 unit of 
DreamTaq Enzyme (Fermentas). The cycle conditions were as 
follows: 94°C for 3 min followed by 35 cycles of 94°C for 45 s, 62°C 
for 45 s, 72°C for 60 s and a final extension at 72°C for 7 min. Re-
actions was held at 4°C. Amplified PCR products were analyzed by 





PCR product was separated on 1% TAE gel and purified by using 
Qiagen gel extraction kit according to the manufacturer’s protocols. 
PCR product was then cloned with InsTAclone PCR Cloning kit 
(Fermentas) according to the manufacturer's protocol. In brief, 10 ul 
of PCR product was mixed with 3 ul of TA vector, 10 ul of water, 6 
ul of 5 x buffers and 1 ul of ligase enzyme. The ligation mix was 
incubated at 4°C for 16 h and then transformed into BL 10 compe-
tent cells by heat shock method. 40 ul of 5-bromo-4-chloro-3-
indolyl-b-D-galactopyranoside (X-Gal) and 40 ul of isopropyl -D-1-
thiogalactopyranoside (IPTG) were spread on the agar plate cont-
aining 1% ampicillin; the transformed cells were spread on it and 





Clones were subjected to sequencing by using Beckman coulter 
CEQ 8000. The sequencing reaction contained 5 ul of template 
DNA, 6 ul of water, 1 ul of core specific sense or antisense primer 
and 8 ul of dye terminator cycle sequencing (DTCS) mix. The 
thermo cycler conditions for sequencing reaction were 96°C for 20 
s, 50°C for 20 s, 60°C for 4 min for 30 cycles followed by final hold 
at 4°C. 5 ul of stop solution containing 2 ul of 3 M sodium acetate, 2 
ul of 100 mM disodium EDTA and 1 ul of 20 mg/ml of glycogen was 
added to each tube. The sequencing reaction containing stop 
solution was then washed with 100% followed by 70% ethanol and 
vacuum dried. The pellet was resuspended in 40 ul of sample 
loading solution, transferred to the wells of sample plate and placed 
in the sequencer. 
 
 
Sequence comparison and phylogenetic analysis 
 
Three  clones  from  each  patient were taken; their sequencing was 




Table 2. Percentage nucleotide identity of six core isolates with isolate number Pk-ncvi/1 to Pk-ncvi/6 with each other 
and 3a reference strains having isolate name NZL1 and HCV-K3A/650. 
 
Nucleotides Identity (%) 
HCV Isolates 
Pk-ncvi/1 Pk-ncvi/2 Pk-ncvi/3 Pk-ncvi/4 Pk-ncvi/5 Pk-ncvi/6 
NZL1 96 95 96 95 94 94 
HCV-K3A/650 92 93 91 93 90 90 
Pk-ncvi/1 100 95 93 93 92 93 
Pk-ncvi/2 95 100 93 97 91 91 
Pk-ncvi/3 93 93 100 92 91 92 
Pk-ncvi/4 93 97 92 100 91 91 
Pk-ncvi/5 92 91 91 91 100 91 




Table 3. Percentage amino acids identity of six core isolates Pk-ncvi/1 to Pk-ncvi/6 compared with each other and 
3a reference strains with isolate name NZL1 and HCV-K3A/650. 
 
Amino acids Identity (%) 
HCV Isolates 
Pk-ncvi/1 Pk-ncvi/2 Pk-ncvi/3 Pk-ncvi/4 Pk-ncvi/5 Pk-ncvi/6 
NZL1 98 98 94 97 92 92 
HCV-
K3A/650 94 94 91 93 88 89 
Pk-ncvi/1 100 98 93 96 91 91 
Pk-ncvi/2 98 100 93 97 91 91 
Pk-ncvi/3 93 93 100 93 89 87 
Pk-ncvi/4 96 97 93 100 90 90 
Pk-ncvi/5 91 91 89 90 100 86 




done from both sense and antisense primer. These sequences 
were aligned in CLC workbench software (www.clcbio.com) to draw 
a consensus sequence and the consensus sequence was submitted to 
NCBI. Pair wise nucleotides and deduced amino acid sequence 
comparison was done by using Clustal W software (Thompson et 
al., 1994). Phylogenetic analysis of our six isolates with sixty seven 
core sequences from different genotypes was performed by using 





Cloning and sequencing 
 
HCV core region was amplified by using specific sense 
and antisense primers, a single band of 573 base pairs 
was obtained and was cloned in TA vector (Fermentas). 
Positive clones were identified on the basis of blue/white 
colony selection. 10-15 white colonies were selected from 
each patient, clone confirmation was done by colony 
PCR and mini prep followed by restriction digestion. 
Three random colonies from each patient were subjected 
to sequencing and their sequences were aligned in CLC 
workbench (www.clcbio.com) to draw the consensus seq-
uence. The sequence similarity rates between the clones 
generated from one patient sample was 99%. Consensus 
core gene sequences from six different patients with 
isolate number Pk-ncvi/1 to Pk-ncvi/6 were submitted to 





Pair wise nucleotides and deduced amino acid sequence 
comparison of our six isolates Pk-ncvi/1 to Pk-ncvi/6 were 
performed with each other and two reference strains of 
HCV 3a genotype with isolate name NZL1 (Sakamoto et 
al., 2004) and HCV-K3A/650 (Yamada et al., 1994) as 
shown in Tables 2 and 3. Highest nucleotides identity 
(97%) was observed between Pk-ncvi/2 and Pk-ncvi/4 
while lowest nucleotides identity (90%) was observed 
between Pk-ncvi/5 and Pk-ncvi/6 with HCV-K3A/650 
(Yamada et al., 1994).  Highest amino acids identity 
(98%) was observed between Pk-ncvi/1 and Pk-ncvi/2 
with each other and with NZL1 (Sakamoto et al., 2004), 
while lowest amino acids identity (86%) was observed 
between Pk-ncvi/5 and Pk-ncvi/6.  
We found two clusters of basic residues in N-terminus 
of deduced amino acid sequences of core HCV dominated 




by arginine, first cluster starts at position 9 and ends at 
position 18. In this cluster, 4 out of 10 amino acids are 
arginine. However in isolate Pk-ncvi/3, arginine at 
position 9 and 18 is substituted to glycine which is non 
polar in nature, and in Pk-ncvi/5 at position 17, arginine is 
replaced by tyrosine. In contrast to this, in isolate Pk-
ncvi/4, an additional arginine is present at position 7. 
Second cluster of arginine is present at position 39 - 70 
where eleven out of thirty two residues are arginine. In 
our isolates, leucine at position 139 and valine at position 
140 are highly conserved; however position 144 is occu-
pied by valine instead of leucine except in Pk-ncvi/6. Se-
rine at position 173, phenylalanine 177 and leucine 179 is 
highly conserved in all the sequences while leucine 182 





Six different core gene sequences of HCV reported in this 
study along with sixty seven core sequences obtained 
from NCBI with different genotypes were used for the 
construction of phylogenetic tree as shown in Figure 1.  
Hepatitis C virus genotypes are mostly grouped into 
single cluster in the tree. There are twenty HCV 3a 
sequences, grouped into Cluster I and Cluster II, out of 
which six are our newly reported sequences, twelve seq-
uences are from the Centre of Excellence in Molecular 
Biology (CEMB) Pakistan and two sequences are from 
Japan. Cluster I contains our six sequences with isolate 
number Pk-ncvi/1 to Pk-ncvi/6 along with four other seq-
uences, out of which PKIS-1 and PK3a-C1 are from 
Pakistani origin while NZL1 (Sakamoto et al., 2004) and 
HCV-K3A/650 (Yamada et al., 1994) are from Japan. 
Cluster II contains ten different isolates from Pakistani 
origin. Amino acid sequence comparison of Cluster I and 





In this study, we reported six core gene sequences of 
HCV isolated from patients of Pakistani population along 
with their sequence comparison and phylogenetic anal-
ysis. This is the first phylogenetic analysis of any HCV 
gene from Pakistani population. It was reported that two 
clusters of basic residues in N-terminus of HCV core are 
important for encapsidation and substitution of as few as 
four basic residues to alanine in either cluster of basic 
residues or removing the cluster, which significantly 
affects the assembly (Klein et al., 2005). 
In Pk-ncvi/5 at position 17, arginine is replaced by 
tyrosine; this substitution might have some effect on 
encapsidation. In isolate Pk-ncvi/4, an additional arginine 
at position 7 enhances the overall strength of the basic 
residues. Second cluster of arginine is present at position 





arginine. These residues might also have some important 
function, since these are conserved in reference as well 
as in our reported sequences. Cleavage by signal peptide 
peptidase requires a signal sequence and three hydro-
phobic residues: Leucine 139, Valine 140 and Leucine 
144 (Okamoto et al., 2004). In our isolates, leucine at 
position 139 and valine at position 140 are highly conser-
ved, however position 144 is occupied by valine instead 
of leucine except in Pk-ncvi/6. Thus it seems that valine 
is more common at this position than leucine as reported 
by Okamoto et al. (2004). Serine 173 (Chang et al., 
1994), phenylalanine 177, leucine 179 (Okamoto et al., 
2004) and leucine 182 (Hussy et al., 1996) have been 
reported as potential cleavage sites for signal peptide 
peptidase; these are conserved in our reported seq-
uences except in leucine 182.  
Pair wise nucleotide and deduced amino acid seq-
uence comparison of our six sequences with two reported 
full length 3a strains from Japanese origin was perform-
ed. Nucleotide sequence comparison showed that our 
sequences have 94 to 96% homology with NZL1 
(Sakamoto et al., 2004) strain and 90 to 93% homology 
with HCV-K3A/650 (Yamada et al., 1994) strain. Deduced 
amino acid sequence comparison showed that our seq-
uences have 92 to 98% homology with NZL1 (Sakamoto 
et al., 2004) strain and 88 to 94% homology with HCV-
K3A/650 (Yamada et al., 1994) strain. Nucleotide and 
deduced amino acid sequence comparison showed that 
our sequences have high homology with 3a reported seq-
uences from Japan. 
Phylogenetic tree was constructed by using six core 
sequences reported in this study and sixty seven core 
sequences from different genotypes. Phylogenetic analy-
sis showed that 3a sequences are grouped in two 
clusters. Our six core sequences with four other seq-
uences, two from Japan and two from Pakistan, are 
grouped in Cluster I. Cluster II contains ten different 3a 
sequences from Pakistani origin. Cluster I suggest that 
our isolates and Japanese isolates have high homology 
and grouped into same cluster. 
Amino acid sequence comparison of Cluster I and 
Cluster II was performed. At position 72, glutamic acid 
was present in all the members of Cluster I, while in Clus-
ter II it was replaced by aspartic acid. Position 182 was 
occupied by phenylalanine in most of the isolates from 
Cluster I while in Cluster II, it was replaced by leucine. 
Amino acid sequence comparison of Cluster I showed 
that our six isolates and two isolates form Japanese 
origin have some common ancestral origin. Cluster II 
contains a serine rich region and three amino acids 
addition at the C-terminus of core sequence. These sub-
stitution at C-terminus do not have any effect on encap-
sidation (Lorenzo et al., 2001; Kunkel et al., 2001) but 
may have effect on signal peptide for the downstream 
envelope protein E1 (Chang et al., 1994). Further study is 
required to check the effect of various amino acid sub-
stitutions on  core  encapsidation,  RNA  binding, nuclear  






Figure 1. Phylogenetic tree of core gene sequences of HCV. Tree was generated by Neighbor joining algorithm. Boot strap values are shown 
on the branches. Tree shows the phylogenetic relationship of six newly reported sequences, marked in boxes, with 67 other core gene 
sequences. The isolate (genotype)/country of the sequences are shown in figure. Tree was constructed by using CLC workbench software. 
Genotypes 3a is grouped in cluster I and cluster II. 






Figure 2. Amino acid sequence alignment of Cluster I and Cluster II of phylogenetic tree.  First ten 
sequences are from Cluster I, remaining eight sequences are from Cluster II, showing amino acid 





localization, association with mitochondrial and endo-





This work was supported by Pak-US Science and Tech-
nology cooperative program entitled “HCV management 
in Pakistan” and Higher Education Commission of Pakis-





Chang SC, Yen JH, Kang HY, Jang MH, Chang MF (1994). Nuclear 
localization signals in the core protein of hepatitis C virus. Biophys. 
Res. Commun. 205: 1284-1290. 
Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M 
(1989). Isolation of a cDNA derived from a blood-borne non-A, non-B 
hepatitis genome. Science, 244: 359-362.  
Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, Wang SY, Tong 
LX (2009). Polymorphism of some cytokines and chronic hepatitis B 
and C virus infection. World J. Gastroenterol. 15(44): 5610-5619 
Hussy P, Langen H, Mous J, Jacobsen H (1996). Hepatitis c virus core 
protein: carboxy terminal boundries of two processed species 
suggest cleavage by a signal peptide peptidase. Virology, 224: 93-
104. 
Klein KC, Dellos S, Lingappa JR (2005). Identification of residues in the 
hepatitis C virus core protein that are critical for capsid assembly in a 
cell free system. J. Virol. 79: 6814-6826. 
Kunkel M, Lorinczi M, Rijnbrand R, Lemon SM, Watowich SJ (2001). 
Self assembly of nucleocapsid like particles from recombinant 
hepatitis c virus core protein. J. Virol. 75: 2119-2129. 
Liu XF, Zou SQ, Qiu FZ (2002). Construction of HCV-core gene vector 
and its expression in cholangiocarcinoma. World J. Gastroenterol. 
8(1): 135-138 
Lorenzo LJ, Carrera SD, Falcon V, Acosta-Rivero N, Gonzalez E, Rosa 
MC, Menendez I, Morales  J (2001). Assembly of truncated HCV core 
antigen into virus like particles in E coli. Biochem. Biophys. Res. 
Commun., 281: 962-965. 
Major ME, Feinstone SM (1997). The Mol. Virol. Hepat. C. Hepatol. 25: 
1527-1538.  
Okamoto K, Moriishi K, Miyamura T, Matsuura Y (2004). 
Intermembrane proteolysis and endoplasmic reticulum retention of 
hepatitis c virus core protein. J. Virol. 78: 6370-6380.  
Rice CM (1996). Flaviviridae: the viruses and their replication, In Fields 
BN, Knipe DM, Howley PM (ed.), Fields virology. Lippincott-Raven 
Publishers, Philadelphia, Pa. pp. 931-960. 
Sakamoto M, Akahane Y, Tsuda F,Tanaka T, Woodfield DG, Okamoto 
H (1994). Entire nucleotide sequence and characterization of a 
hepatitis C virus genotype V/3a. J. Gen. Virol. 75: 1761-1768. 
Santolini E, Migliaccio G, Monica NL (1994) Biosynthesis and 





 68: 3631-3641. 
Schwer B, Ren S, Pietschmann T, Kartenbeck J, Kaehlcke K, 
Bartenschlager R, Yen TS, Ott M (2004). Targeting of hepatitis C 
virus core protein to mitochondria through a novel C-terminal 
localization motif. J. Virol. 78: 7958-7968.  
Thompson JD, Higgins DG, Gibson TJ (1994). Clustal W: improving the 
sensitivity of progressive multiple sequence alignment through 
sequence weighting, postion-spiecific gap penalties and weight 
matrix choice. Nucleic Acids Res. 22: 4673-4680.  
Turhan V, Ardic N, Eyigun CP et al. (2005). Investigation of genotype 
distribution of hepatitis C virus among Turkish population in Turkey 
and various European countries. Chin. Med. J. 118: 1392-1394. 
Waheed Y, Shafi T, Safi SZ, Qadri I (2009). Hepatitis C virus in 
Pakistan: A systematic review of prevalence, genotypes and risk 
factors. World J. Gasteroenterol. 15: 5647-5653. 
Yamada N, Tanihara K, Mizokami M, Ohba K, Takada A, Tsutsumi M, 
Date T (1994). Full length sequence of the genome of Hepatitis C 
virus type 3a: comparative study with different genotypes. J. Gen. 











Yan XB, Mei L, Feng X, Wan MR, Chen Z, Pavio N, Brechot C (2008). 
Hepatitis C virus core proteins derived from different quasispecies of 
genotype 1b inhibit the growth of Chang liver cells. World J. 
Gastroenterol. 14: 2877-2881 
Yasui K, Wakita T, Kohara KT Funahasi SI, Ichikawa M. Kajita T, 
Moradpour D, Wands JR, Kohara M (1998). The native form and 
maturation process of hepatitis C virus core protein. J. Virol. 72: 
6048-6055.  
Zhu LX, Liu J, Li YC, Kong YY, Staib C, Sutter G, Wang Y, Li GD 
(2002). Full-length core sequence dependent complex-type 
glycosylation of hepatitis C virus glycoprotein. World J. Gastroenterol. 
8: 499-504. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
